From: Impact of pharmacist-led aminoglycoside stewardship: a 10-year observational study
 | Before intervention N = 123 | After intervention N = 140 | P-value |
---|---|---|---|
Clinical efficacy | |||
Effective | 80 (65%) | 99 (71%) | P = 0.35a |
Not effective | 30 (24%) | 29 (21%) | Â |
Unnecessary use | 13 (11%) | 12 (8.6%) | Â |
Adverse events | |||
Renal impairmentb | 13 (11%) | 17 (12%) | P = 0.85 |
Discontinuation due to adverse events | 6 (4.9%) | 10 (7.1%) | P = 0.61 |
Kidney injury | 5 (4.1%) | 3 (2.1%) | P = 0.48 |
Ototoxicity | 0 (0%) | 1 (0.7%) | P = 1.00 |
Skin rash | 0 (0%) | 2 (1.4%) | P = 0.50 |
Hepatic injury | 0 (0%) | 2 (1.4%) | P = 0.50 |
Diarrhea | 1 (0.8%) | 0 (0%) | P = 0.47 |
Loss of appetite | 0 (0%) | 1 (0.7) | P = 1.00 |
Death | 6 (4.9%) | 5 (3.6%) | P = 0.76 |